Home
About
FAQ
History (13)
Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria.
Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors.
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
Session III: Mechanisms of age-related cognitive change and targets for intervention: inflammatory, oxidative, and metabolic processes.
Carboxypeptidases
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (6)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Herbert L. Bonkovsky MD
Wake Forest School of Medicine
Why?
Jeffrey C. Gardner MD
Wake Forest School of Medicine
Why?
Roger L. Royster MD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 1
Next
Prev
Search Criteria
Splanchnic Circulation
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions